论文部分内容阅读
目的观察甲氰咪胍治疗过敏性紫癜的疗效。方法将90例患儿分为甲氰咪胍治疗组42例与对照组48例,对比两组的临床疗效。结果观察组总有效率92.9%,对照组总有效率75.0%,治疗组临床症状消失时间明显少于对照组,两组患者症状消失时间比较差异无统计学意义。治疗组复发率明显低于对照组,两组比较差异有统计学意义。结论甲氰咪胍是治疗过敏性紫癜安全有效的药物。
Objective To observe the effect of cimetidine in the treatment of Henoch-Schonlein purpura. Methods 90 children were divided into cimetidine treatment group 42 cases and control group 48 cases, the clinical efficacy of the two groups were compared. Results The total effective rate was 92.9% in the observation group and 75.0% in the control group, and the disappearance time of the clinical symptoms in the treatment group was less than that in the control group. There was no significant difference in the disappearance time between the two groups. The recurrence rate of the treatment group was significantly lower than that of the control group, the difference between the two groups was statistically significant. Conclusion Cimetidine is a safe and effective drug for the treatment of allergic purpura.